145 related articles for article (PubMed ID: 8520725)
1. Adrenoleukodystrophy: molecular genetics, pathology, and Lorenzo's oil.
Moser HW; Powers JM; Smith KD
Brain Pathol; 1995 Jul; 5(3):259-66. PubMed ID: 8520725
[TBL] [Abstract][Full Text] [Related]
2. [Lorenzo's oil. A realistic presentation of two parents' fight against adrenoleukodystrophy].
Söderfeldt B
Lakartidningen; 1993 May; 90(20):1969-72. PubMed ID: 8502039
[No Abstract] [Full Text] [Related]
3. Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil".
van Geel BM; Assies J; Haverkort EB; Koelman JH; Verbeeten B; Wanders RJ; Barth PG
J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):290-9. PubMed ID: 10449548
[TBL] [Abstract][Full Text] [Related]
4. Lorenzo's oil therapy of adrenoleukodystrophy.
DiGregorio VY; Schroeder DJ
Ann Pharmacother; 1995 Mar; 29(3):312-3. PubMed ID: 7606079
[No Abstract] [Full Text] [Related]
5. More on Lorenzo's oil.
Odone A; Odone M
N Engl J Med; 1994 Jun; 330(26):1904-5. PubMed ID: 8196741
[No Abstract] [Full Text] [Related]
6. Treatment of X-linked adrenoleukodystrophy with Lorenzo's oil.
Moser HW
J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):279-80. PubMed ID: 10449544
[No Abstract] [Full Text] [Related]
7. Lorenzo's oil and thrombocytopenia in patients with adrenoleukodystrophy.
Zinkham WH; Kickler T; Borel J; Moser HW
N Engl J Med; 1993 Apr; 328(15):1126-7. PubMed ID: 8455677
[No Abstract] [Full Text] [Related]
8. Lorenzo's oil--hope and disappointment.
Rizzo WB
N Engl J Med; 1993 Sep; 329(11):801-2. PubMed ID: 8043042
[No Abstract] [Full Text] [Related]
9. Lorenzo's oil: a reassessment.
Poulos A; Robertson EF
Med J Aust; 1994 Mar; 160(6):315-7. PubMed ID: 8133809
[No Abstract] [Full Text] [Related]
10. Evaluation of the preventive effect of glyceryl trioleate-trierucate ("Lorenzo's oil") therapy in X-linked adrenoleukodystrophy: results of two concurrent trials.
Moser HW; Raymond GV; Koehler W; Sokolowski P; Hanefeld F; Korenke GC; Green A; Loes DJ; Hunneman DH; Jones RO; Lu SE; Uziel G; Giros ML; Roels F
Adv Exp Med Biol; 2003; 544():369-87. PubMed ID: 14713253
[No Abstract] [Full Text] [Related]
11. Lorenzo's oil and lymphocytopenia.
Unkrig CJ; Schröder R; Scharf RE
N Engl J Med; 1994 Feb; 330(8):577. PubMed ID: 8204158
[No Abstract] [Full Text] [Related]
12. Adrenoleukodystrophy: magnetic resonance follow-up after Lorenzo's oil therapy.
Duchesne N; Dufour M; Bouchard G; Grondin P; Lemieux B
Can Assoc Radiol J; 1995 Oct; 46(5):386-91. PubMed ID: 7552831
[TBL] [Abstract][Full Text] [Related]
13. Normal natural killer cell activity in a patient with adrenoleukodystrophy treated with Lorenzo's oil.
Tanaka M; Koike R; Kuwabara T
Neurodegeneration; 1996 Jun; 5(2):192-4. PubMed ID: 8819141
[No Abstract] [Full Text] [Related]
14. Improvement of clinical and MRI findings in a boy with adrenoleukodystrophy by dietary erucic acid therapy.
Maeda K; Suzuki Y; Yajima S; Asano J; Yamaguchi S; Matsumoto N; Borel J; Moser HW; Orii T
Brain Dev; 1992 Nov; 14(6):409-12. PubMed ID: 1492654
[TBL] [Abstract][Full Text] [Related]
15. Lorenzo's oil: advances in the treatment of neurometabolic disorders.
Ferri R; Chance PF
Arch Neurol; 2005 Jul; 62(7):1045-6. PubMed ID: 16009756
[No Abstract] [Full Text] [Related]
16. Severely depressed natural killer cell activity of patients with adrenoleukodystrophy under treatment with Lorenzo's oil.
Sedlmayr P; Plecko B; Paschke E; Zenz W; Ramschak H; Toplak H; Wascher TC; Wilders-Truschnig M; Stöckler S
J Inherit Metab Dis; 1995; 18(1):101-2. PubMed ID: 7623436
[No Abstract] [Full Text] [Related]
17. Komrower Lecture. Adrenoleukodystrophy: natural history, treatment and outcome.
Moser HW
J Inherit Metab Dis; 1995; 18(4):435-47. PubMed ID: 7494402
[TBL] [Abstract][Full Text] [Related]
18. Lorenzo oil therapy for adrenoleukodystrophy: a prematurely amplified hope.
Moser HW
Ann Neurol; 1993 Aug; 34(2):121-2. PubMed ID: 8338333
[No Abstract] [Full Text] [Related]
19. Plasma and red blood cell fatty acids in peroxisomal disorders.
Moser AB; Jones DS; Raymond GV; Moser HW
Neurochem Res; 1999 Feb; 24(2):187-97. PubMed ID: 9972864
[TBL] [Abstract][Full Text] [Related]
20. Enhanced lymphocyte proliferation in patients with adrenoleukodystrophy treated with erucic acid (22:1)-rich triglycerides.
Pour RB; Stöckler-Ipsiroglu S; Hunneman DH; Gahr M; Korenke GC; Pabst W; Hanefeld F; Peters A
J Inherit Metab Dis; 2000 Mar; 23(2):113-9. PubMed ID: 10801052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
